Stryker Corp. Stock Takes a Dive on Monday as Market Struggles.
December 7, 2023
🌧️Trending News
Monday was a tough day for Stryker ($NYSE:SYK) Corp. stock, as it failed to keep pace with the market and ended the day with a decrease in its value. The company specializes in medical devices and equipment for orthopedic surgery, neurosurgery, and other medical specialties. The market as a whole was struggling on Monday, with many stocks taking a dive. Stryker Corp. was no exception, as their stock declined by a significant amount. The company had recently seen some success in expanding its portfolio of products, which had helped boost their stock prices.
However, the Monday decline wiped out much of these gains and left investors uncertain about the company’s future.
Market Price
Monday was a tough day for STRYKER CORPORATION stock, as it opened at $295.8 and closed at $291.0, a drop of 2.3% from the previous closing price of $297.8. The company’s shares had been performing well in the weeks prior, but failed to hold onto its gains on Monday. Analysts are now speculating whether this could be a hangover from last week’s performance, or whether it could be attributed to something more fundamental. Stryker Corporation is currently facing a number of macroeconomic headwinds, including the unpredictable nature of the coronavirus pandemic, which has had an impact on its business operations and earnings.
It remains to be seen whether STRYKER CORPORATION will be able to regain its footing and start trending upwards once again, or if Monday’s drop marks the beginning of a longer-term trend. In the meantime, investors will be keeping a close eye on the company’s stock and any potential news that could affect its performance. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Stryker Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 19.89k | 2.58k | 13.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Stryker Corporation. More…
| Operations | Investing | Financing |
| 3.19k | -972 | -1.75k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Stryker Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 38.04k | 20.14k | 47.13 |
Key Ratios Snapshot
Some of the financial key ratios for Stryker Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.8% | 14.5% | 18.3% |
| FCF Margin | ROE | ROA |
| 12.9% | 12.9% | 6.0% |
Analysis
GoodWhale conducted an analysis of STRYKER CORPORATION‘s wellbeing, and based on the Star Chart, we classified STRYKER CORPORATION as a ‘gorilla’– a company that has achieved stable and high revenue or earning growth due to its strong competitive advantage. Investors interested in such a company include growth investors and value investors looking for steady dividend growth. STRYKER CORPORATION earned a health score of 8/10 with regard to its cashflows and debt, indicating that the company is in a good position to pay off debt and fund future operations. Overall, STRYKER CORPORATION performed strongly in dividend, growth, and profitability, while its performance in assets was regarded as average. More…
Peers
Stryker Corporation is one of the world’s largest medical technology companies. It offers a broad range of products including orthopedic implants, surgical instruments, medical equipment and software solutions. The company operates in over 100 countries and has a strong presence in the United States, Europe and Asia. Stryker’s competitors include Fukuda Denshi Co Ltd, Nihon Kohden Corp and Shanghai Sanyou Medical Co Ltd.
– Fukuda Denshi Co Ltd ($TSE:6960)
Fukuda Denshi Co. Ltd., together with its subsidiaries, manufactures and sells medical electronic equipment in Japan and internationally. The company operates through five segments: Diagnostic Cardiology, Diagnostic Imaging, Patient Monitoring, Electrotherapy, and Others. It offers diagnostic cardiology products, including electrocardiographs, stress test systems, Holter systems, ambulatory blood pressure monitors, and medical printers; and diagnostic imaging products comprising X-ray diagnostic systems, computed tomography systems, magnetic resonance imaging systems, ultrasound diagnostic systems, X-ray angiography systems, and nuclear medicine diagnostic systems. The company also provides patient monitoring products, such as central station systems, telemetry systems, patient monitors, and related accessories; electrotherapy products, such as shortwave diathermy machines and physical therapy equipment; and other products, such as endoscopic and ophthalmologic equipment. It sells its products primarily to general hospitals, clinics, and other health care facilities. The company was founded in 1930 and is headquartered in Tokyo, Japan.
– Nihon Kohden Corp ($TSE:6849)
Nihon Kohden Corp. is a Japanese manufacturer of medical equipment, headquartered in Tokyo. The company was founded in 1952 and has since grown to become a leading supplier of medical equipment in Japan. Nihon Kohden’s product lineup includes everything from patient monitors and electrocardiographs to ultrasound machines and medical robotics. The company also offers a wide range of services, including maintenance and repair services for its products.
Nihon Kohden has a market capitalization of 269.63 billion as of 2022. The company’s return on equity is 11.49%. Nihon Kohden is a leading manufacturer of medical equipment in Japan. The company offers a wide range of products and services, including maintenance and repair services for its products.
– Shanghai Sanyou Medical Co Ltd ($SHSE:688085)
Shanghai Sanyou Medical Co Ltd is a medical company with a market cap of 6.32B as of 2022. The company’s return on equity is 8.85%. Shanghai Sanyou Medical Co Ltd is engaged in the research, development, manufacture, and sale of medical devices and equipment. The company’s products include medical imaging equipment, medical consumables, and medical disposables.
Summary
Stryker Corporation‘s stock performance on Monday was weak compared to the overall market. Investors should consider several factors before investing in Stryker Corporation, such as the company’s financial performance, management track record, business strategy, competitive landscape, and macroeconomic environment. Factors to consider include the company’s revenue, earnings, and free cash flow growth, its strong competitive position in the medical device industry, its durable portfolio of leading products, and its ability to quickly adapt to changes in the healthcare industry. The macroeconomic environment is also a factor to consider when analyzing Stryker Corporation’s stock performance.
It is important to stay up-to-date on the current economic trends and market conditions that could impact the company’s performance. Investing in Stryker Corporation is a decision that should not be taken lightly and should be made after careful analysis of multiple factors.
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
